MRI能否帮助判断有多灶高级别前列腺上皮内瘤变或非典型小腺泡增生史的男性是否仍存在临床显著前列腺癌风险
回顾性分析207例既往诊断为非典型小腺泡增生(ASAP)或多灶高级别前列腺上皮内瘤变(HGPIN)后接受重复活检的男性,比较无MRI、PIRADS≥4和PIRADS≤3三组重复活检≥GG2前列腺癌的比例。PIRADS≥4组为56%,无MRI组为12%(P<.001);PIRADS≤3组为3.0%,无MRI组为12%(P=.13)。校正模型中PIRADS 4-5病变与≥GG2前列腺癌风险升高相关(OR 11.4,P<.001)。
要点
- PIRADS≥4组重复活检≥GG2前列腺癌比例为56%,无MRI组为12%(P<.001)。
- PIRADS≤3组≥GG2前列腺癌比例为3.0%,无MRI组为12%(P=.13)。
- 校正模型中PIRADS 4-5病变与≥GG2前列腺癌风险升高相关(OR 11.4,P<.001)。
核心结论
- MRI是分诊既往ASAP或多灶HGPIN男性是否需重复活检的有价值诊断工具,可避免遗漏临床显著前列腺癌。
研究设计与样本
- 回顾性研究,纳入密歇根泌尿外科手术改进协作组注册的207例既往ASAP或多灶HGPIN后接受重复活检的男性。
- 纳入指数活检后、重复活检前有或无MRI的男性,排除指数活检前已行MRI者。
- 采用χ2检验比较无MRI、PIRADS≥4和PIRADS≤3三组重复活检≥GG2前列腺癌比例,并用多变量模型估计校正关联。
主要发现
- PIRADS≥4组重复活检≥GG2前列腺癌比例为56%,无MRI组为12%(P<.001)。
- PIRADS≤3组重复活检≥GG2前列腺癌比例为3.0%,无MRI组为12%(P=.13)。
- 校正模型中PIRADS 4-5病变与重复活检≥GG2前列腺癌风险升高相关(OR 11.4,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the association of MRI findings in men with a previous diagnosis of atypical small acinar proliferation (ASAP) or multifocal high-grade intraepithelial neoplasia (HGPIN) with pathologic findings on repeat biopsy. MATERIALS AND METHODS: We retrospectively reviewed patients with ASAP/multifocal HGPIN undergoing a repeat biopsy in the Michigan Urological Surgery Improvement Collaborative registry. We included men with and without an MRI after the index biopsy demonstrating ASAP/multifocal HGPIN but before the repeat biopsy. Men with an MRI prior to the index biopsy were excluded. We compared the proportion of men with ≥ GG2 CaP (Grade Group 2 prostate cancer) on repeat biopsy among the following groups with the χ2 test: no MRI, PIRADS (Prostate Imaging-Reporting and Data System) ≥ 4, and PIRADS ≤ 3. Multivariable models were used to estimate the adjusted association between MRI findings and ≥ GG2 CaP on repeat biopsy. RESULTS: Among the 207 men with a previous diagnosis of ASAP/multifocal HGPIN that underwent a repeat biopsy, men with a PIRADS ≥ 4 lesion had a higher proportion of ≥ GG2 CaP (56%) compared with men without an MRI (12%, P < .001). A lower proportion of men with PIRADS ≤ 3 lesions had ≥ GG2 CaP (3.0%) compared with men without an MRI (12%, P = .13). In the adjusted model, men with a PIRADS 4 to 5 lesion had higher odds (OR: 11.4, P < .001) of ≥ GG2 CaP on repeat biopsy. CONCLUSIONS: MRI is a valuable diagnostic tool to triage which men with a history of ASAP or multifocal HGPIN on initial biopsy should undergo or avoid repeat biopsy without missing clinically significant CaP.
引用
- Sessine MS, Radoiu CS, Qi J, et al. Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer? J Urol. 2023. PMID: 37930976. doi:10.1097/JU.0000000000003775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。